Bharat Biotechs Covaxin Set For Trials On Children
Bharat Biotech’s Covaxin Set For Trials On Children
Amid an ongoing struggle to vaccinate all above 18, Bharat Biotech was on Tuesday recommended by an expert panel to send its COVID-19 vaccine ‘Covaxin’ for phase II and phase III clinical trials on children between the age of two and 18 years.